Lineage Cell Therapeutics Inc.
LCTX | AMEX
$1.04
+$0.03 (+2.97%)
At close: Sep 22, 2026, 4:00 PM ET
$1.03
-$0.01 (-0.96%)
After-hours:
Sep 22, 2026, 5:15 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -32.13M | -63.98M | -63.31M | -67.53M | -40.81M | -16.21M | -18.63M | -20.13M | -24.25M | -23.69M | -21.54M | -23.13M | -22.04M | -23.62M | -26.31M | -49.13M | -50.9M | -48.91M | -43.26M | -12.03M | -11.96M | -13.7M |
Depreciation & Amortization | 739K | 723K | 699K | 664K | 627K | 598K | 609K | 633K | 668K | 696K | 692K | 690K | 692K | 701K | 708K | 726K | 747K | 776K | 884K | 1.03M | 1.28M | 1.62M |
Stock-Based Compensation | 5.07M | 4.71M | 4.75M | 4.97M | 5.1M | 5.13M | 5.08M | 4.82M | 4.76M | 4.77M | 4.64M | 4.54M | 4.26M | 4.21M | 4.29M | 4.25M | 4.4M | 4.09M | 3.52M | 3.1M | 2.45M | 2.14M |
Other Working Capital | -3.25M | -5.77M | -5.9M | -7.23M | -1.96M | -280K | -1.19M | -387K | -4.1M | -6.6M | -7.97M | -8.83M | -11.35M | -13.02M | -33.25M | -29.56M | -27.8M | -22.72M | 404K | -187K | 693K | 252K |
Other Non-Cash Items | 9.28M | 47.68M | 48.33M | 48.72M | 16.13M | -9.36M | -7.14M | -6.31M | -182K | -653K | -920K | -464K | 989K | 4.14M | 4.63M | 4.62M | 5.3M | 1.17M | 686K | -5.82M | -6.64M | -4.61M |
Deferred Income Tax | -5.28M | -5.28M | -5.28M | n/a | n/a | n/a | n/a | -554K | 387K | 1.08M | -720K | -166K | -1.11M | -1.8M | n/a | 1.18M | 169K | n/a | -5.57M | -7.81M | -6.98M | -6.81M |
Change in Working Capital | -1.49M | -5.96M | -4.11M | -7.21M | -3.6M | -2.36M | -3.02M | -1.23M | -3.4M | -5.31M | -10.72M | -12.32M | -13.1M | -14.74M | 18.73M | 42.84M | 44.41M | 49.56M | 21.1M | -879K | -563K | -803K |
Operating Cash Flow | -23.82M | -22.11M | -18.92M | -20.39M | -22.56M | -22.2M | -23.09M | -22.77M | -22.02M | -23.11M | -28.57M | -30.85M | -31.29M | -32.09M | 1.06M | 3.49M | 4.12M | 5.77M | -23.56M | -23.33M | -23.33M | -22.15M |
Capital Expenditures | -123K | -192K | -234K | -488K | -388K | -424K | -365K | -91K | -318K | -524K | -674K | -567K | -714K | -555K | -413K | -575K | -357K | -389K | -354K | -232K | -188K | -65K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.26M | -21.68M | -21.49M | -21.49M | -19.23M | 188K | n/a | n/a | n/a | 14K | 10.1M | 11.02M | 11.23M | 11.22M |
Purchase of Investments | -33.6M | -23.17M | -14.94M | n/a | n/a | -8.76M | -8.76M | -8.76M | -12.53M | -8.69M | -16.4M | -29.19M | -66.05M | -61.13M | -53.41M | -40.63M | n/a | n/a | -10.07M | 6.61M | 6.41M | 6.41M |
Sales Maturities Of Investments | 20.46M | 5.97M | 2M | 5M | 9M | 9.02M | 7.02M | 13.85M | 15.88M | 40.19M | 63.53M | 53.69M | 47.66M | 23.33M | n/a | n/a | n/a | n/a | -6.02M | -22.72M | -22.51M | -22.51M |
Other Investing Acitivies | -451K | -288K | -288K | n/a | -200K | -200K | -200K | -200K | 2.26M | 21.68M | 21.49M | 29.15M | 26.89M | 7.48M | 7.67M | n/a | n/a | n/a | 6.02M | 6.05M | 6.02M | 12.73M |
Investing Cash Flow | -13.71M | -17.69M | -13.46M | 4.51M | 8.41M | -367K | -2.31M | 4.8M | 3.03M | 30.99M | 46.45M | 31.61M | -11.43M | -30.69M | -46.16M | -41.2M | -357K | -375K | 9.75M | 10.79M | 11.04M | 17.86M |
Debt Repayment | -45K | -59K | -59K | -58K | -55K | -55K | -54K | -53K | -52K | -54K | -54K | -50K | -46K | -37K | -32K | -30K | -35K | -28K | -20K | -15K | -9K | -18K |
Common Stock Repurchased | n/a | n/a | -15K | -15K | -15K | -15K | -23K | -222K | -222K | -222K | -236K | -37K | -37K | -46K | -17K | -30K | -44K | -49K | -54K | -49K | -41K | -38K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.19M | -501K | -685K | -742K | -513K | -199K | 157K | 414K | 400K | 169K | 88K | 20K | 1.01M | 1.2M | 1.53M | 2.25M | 2.1M | 5.42M | 6.14M | 4.99M | 28.74M | 25.89M |
Financial Cash Flow | 32.24M | 27.47M | 26.95M | 28.31M | 26.47M | 26.88M | 35.86M | 14.11M | 14.92M | 20.44M | 6.42M | 6.56M | 6.72M | 1.12M | 1.63M | 2.46M | 5.22M | 16.48M | 36.93M | 40.79M | 61.63M | 50.84M |
Net Cash Flow | -4.33M | -11.87M | -5.03M | 12.67M | 12.61M | 4.22M | 10.36M | -3.69M | -4.28M | 28.1M | 24.06M | 6.7M | -36.41M | -62.08M | -43.84M | -35.53M | 8.85M | 21.88M | 23.09M | 28.18M | 49.26M | 46.33M |
Free Cash Flow | -23.94M | -22.3M | -19.15M | -20.88M | -22.95M | -22.62M | -23.46M | -22.86M | -22.33M | -23.63M | -29.24M | -31.42M | -32.01M | -32.64M | 646K | 2.91M | 3.76M | 5.38M | -23.92M | -23.56M | -23.52M | -22.22M |
Adj. Free Cash Flow | -29.01M | -27.01M | -23.91M | -25.84M | -28.05M | -27.75M | -28.53M | -27.68M | -27.09M | -28.4M | -33.88M | -35.96M | -36.26M | -36.85M | -3.64M | -1.33M | -638K | 1.29M | -27.43M | -26.66M | -25.97M | -24.36M |
Maintenance CapEx | -122K | -67K | -67.85K | -67.85K | 120.15K | 70.15K | 88K | 88K | -227K | -433K | -583K | -551K | -412K | -156K | 32K | n/a | n/a | n/a | n/a | -24K | -24K | -30K |
Growth CapEx | -1K | -125K | -166.15K | -420.15K | -508.15K | -494.15K | -453K | -179K | -91K | -91K | -91K | -16K | -302K | -399K | -445K | -575K | -357K | -389K | -354K | -208K | -164K | -35K |
Owner Earnings | -23.94M | -22.18M | -18.99M | -20.45M | -22.44M | -22.12M | -23M | -22.68M | -22.24M | -23.54M | -29.15M | -31.4M | -31.71M | -32.24M | 1.09M | 3.49M | 4.12M | 5.77M | -23.56M | -23.35M | -23.35M | -22.18M |
Add to Watchlist
Select watchlists to add or remove LCTX